Johnson Investment Counsel’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Sell
13,288
-1,576
-11% -$138K 0.01% 442
2026
Q1
$1.34M Sell
14,864
-4,270
-22% -$392K 0.01% 384
2025
Q4
$1.72M Sell
19,134
-9,796
-34% -$929K 0.01% 332
2025
Q3
$2.85M Sell
28,930
-17,924
-38% -$1.78M 0.02% 245
2025
Q2
$4.27M Sell
46,854
-22,675
-33% -$2.19M 0.04% 185
2025
Q1
$7.87M Sell
69,529
-48,531
-41% -$5.19M 0.08% 131
2024
Q4
$12.5M Sell
118,060
-272,311
-70% -$29.2M 0.12% 105
2024
Q3
$42.1M Sell
390,371
-167,568
-30% -$18.3M 0.41% 65
2024
Q2
$60.6M Sell
557,939
-2,317
-0.4% -$273K 0.64% 51
2024
Q1
$73.9M Buy
560,256
+6,059
+1% +$757K 0.8% 40
2023
Q4
$67.4M Buy
554,197
+1,433
+0.3% +$160K 0.79% 42
2023
Q3
$62M Buy
552,764
+18,448
+3% +$2.34M 0.8% 41
2023
Q2
$77.8M Sell
534,316
-7,834
-1% -$1.06M 0.97% 35
2023
Q1
$70M Sell
542,150
-29,891
-5% -$3.75M 0.93% 36
2022
Q4
$72.9M Sell
572,041
-22,507
-4% -$2.61M 1% 37
2022
Q3
$62.2M Sell
594,548
-18,103
-3% -$1.99M 0.92% 41
2022
Q2
$64.4M Sell
612,651
-11,464
-2% -$1.36M 0.91% 37
2022
Q1
$80.1M Sell
624,115
-47,660
-7% -$5.74M 0.99% 28
2021
Q4
$83M Sell
671,775
-31,840
-5% -$4.17M 1.02% 29
2021
Q3
$100M Buy
703,615
+36,363
+5% +$5.35M 1.34% 15
2021
Q2
$104M Buy
667,252
+21,545
+3% +$3.49M 1.44% 15
2021
Q1
$101M Buy
645,707
+19,710
+3% +$3.05M 1.51% 10
2020
Q4
$93.8M Buy
625,997
+11,849
+2% +$1.67M 1.56% 13
2020
Q3
$81.3M Buy
614,148
+13,952
+2% +$1.82M 1.51% 14
2020
Q2
$69.7M Sell
600,196
-415,579
-41% -$47.9M 1.41% 15
2020
Q1
$123M Buy
1,015,775
+520,878
+105% +$68.3M 2.73% 6
2019
Q4
$72M Buy
494,897
+12,660
+3% +$1.75M 1.36% 16
2019
Q3
$64.4M Buy
482,237
+17,168
+4% +$2.22M 1.28% 16
2019
Q2
$53.2M Buy
465,069
+103,445
+29% +$12.1M 1.1% 22
2019
Q1
$44.8M Sell
361,624
-32,860
-8% -$3.73M 0.96% 32
2018
Q4
$39.7M Sell
394,484
-45,882
-10% -$5.16M 0.97% 28
2018
Q3
$56.2M Buy
440,366
+12,507
+3% +$1.49M 1.25% 17
2018
Q2
$46.3M Buy
427,859
+7,972
+2% +$868K 1.13% 23
2018
Q1
$44.5M Buy
419,887
+40,677
+11% +$4.72M 1.14% 25
2017
Q4
$44.4M Buy
379,210
+19,591
+5% +$2.22M 1.11% 23
2017
Q3
$40.9M Buy
359,619
+4,167
+1% +$481K 1.08% 25
2017
Q2
$44.3M Buy
355,452
+4,744
+1% +$562K 1.23% 17
2017
Q1
$41.6M Buy
350,708
+14,749
+4% +$1.67M 1.2% 14
2016
Q4
$33.7M Buy
335,959
+28,419
+9% +$3.05M 1.04% 29
2016
Q3
$38.8M Sell
307,540
-10,555
-3% -$1.3M 1.24% 15
2016
Q2
$37.2M Buy
318,095
+7,309
+2% +$827K 1.22% 16
2016
Q1
$32.2M Buy
310,786
+54,952
+21% +$5.32M 1.13% 24
2015
Q4
$25.5M Sell
255,834
-5,629
-2% -$551K 0.89% 39
2015
Q3
$23.8M Buy
261,463
+2,541
+1% +$255K 0.88% 42
2015
Q2
$27.5M Buy
258,922
+37,751
+17% +$4.18M 0.92% 40
2015
Q1
$25.2M Buy
221,171
+4,183
+2% +$477K 0.85% 42
2014
Q4
$23.9M Buy
216,988
+209,741
+2,894% +$22.1M 0.79% 46
2014
Q3
$707K Sell
7,247
-161
-2% -$15.8K 0.02% 259
2014
Q2
$746K Sell
7,408
-5
-0.1% -$488 0.03% 224
2014
Q1
$680K Sell
7,413
-440
-6% -$40.6K 0.02% 231
2013
Q4
$710K Sell
7,853
-1,092
-12% -$94.5K 0.03% 231
2013
Q3
$713K Sell
8,945
-132
-1% -$10.4K 0.03% 218
2013
Q2
$660K Buy
+9,077
New +$679K 0.03% 215

Other funds holding ZBH

Johnson Investment Counsel's ZBH Position: Q2 2026 in Review

Johnson Investment Counsel reduced its Zimmer Biomet (ZBH) stake by 11% in Q2 2026, selling an estimated $138K and leaving 13,288 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #442.

Johnson Investment Counsel first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $123M in Q1 2020. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Johnson Investment Counsel held 13,288 shares of Zimmer Biomet worth $1.14M as of Q2 2026.
  • Johnson Investment Counsel sold 1,576 Zimmer Biomet shares in Q2 2026, an estimated $138K.
  • Zimmer Biomet made up 0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #442 holding.
  • Johnson Investment Counsel first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Johnson Investment Counsel's Zimmer Biomet position peaked at $123M in Q1 2020.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.